Menu
Back to User profile » Prof. Dr. Thomas Müller
Papers published by Prof. Dr. Thomas Müller:
No Vitamin D Deficiency in Patients with Parkinson’s Disease
Kuhn W, Karp G, Müller T
Degenerative Neurological and Neuromuscular Disease 2022, 12:127-131
Published Date: 26 September 2022
View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson’s Disease: Are We on the Right Track?
Müller T
Biologics: Targets and Therapy 2021, 15:307-316
Published Date: 29 July 2021
Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
Müller T
Journal of Experimental Pharmacology 2021, 13:397-408
Published Date: 29 March 2021
Editorial announcing PubMed indexing of Degenerative Neurological and Neuromuscular Disease
Müller T
Degenerative Neurological and Neuromuscular Disease 2019, 9:1-2
Published Date: 27 December 2018
Safinamide: an add-on treatment for managing Parkinson’s disease
Müller T
Clinical Pharmacology: Advances and Applications 2018, 10:31-41
Published Date: 5 April 2018
Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
Müller T
Therapeutics and Clinical Risk Management 2016, 12:1151-1160
Published Date: 2 August 2016
The resurgence of neurotransmitter modulation in Parkinson’s disease with safinamide
Müller T
Journal of Parkinsonism and Restless Legs Syndrome 2015, 5:11-17
Published Date: 26 March 2015
Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: efficacy, safety and patient preference
Thomas Müller
Patient Preference and Adherence 2009, 3:51-59
Published Date: 29 January 2009